Update from CredibleMeds
March 31, 2021 Re: Revision to the QTdrugs List We are writing to inform you that two newly marketed drugs in the US, Ponesimod for treatment of
April 7, 2021
No Comments
Latest News
CRY’s myheart network provides personalised help, support, and information to individuals who have been diagnosed with a potentially life-threatening inherited or congenital cardiac condition. myheart is a support system for individuals to help develop effective coping strategies and reduce social isolation.
The network was developed in response to feedback from young people who found that support groups available were not effective in helping them deal with issues such as fitting of ICDs, pacemakers and undergoing ablation surgery. myheart have dedicated resources for young people under the age of 35 who have been diagnosed with a cardiac condition, as well as information and support resources for anyone over the age of 18 who has been diagnosed with a cardiac condition when they thought that they were fit and healthy.
March 31, 2021 Re: Revision to the QTdrugs List We are writing to inform you that two newly marketed drugs in the US, Ponesimod for treatment of
In April of this year, I was diagnosed with Long QT Syndrome (LQTS). In the midst of a pandemic, this was the most unwelcome conclusion
I had no idea at the end of the summer holidays in 2011 that the following months would be a defining period of my life.
myheart cardiologist, Dr Sabiha Gati, will be filming answers to questions our members have about myocarditis to create a FAQ’s about myocarditis. Do you have
Dear myheart members Thank you to all of you who are helping raise funds and awareness of Cardiac Risk in the Young (CRY) and myheart in these
Members with cardiac conditions may like to consider registering with CredibleMeds to be kept up to date with any changes to the QT drugs to
A myheart members’ video meeting is planned between 1pm-3pm on Saturday 17th October, 2020. Registered members can start logging in from 12:45pm. Meetings are free to